International Assets Investment Management LLC Purchases 106,069 Shares of Teladoc Health, Inc. (NYSE:TDOC)

International Assets Investment Management LLC lifted its position in Teladoc Health, Inc. (NYSE:TDOC) by 1,777.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 112,038 shares of the health services provider’s stock after buying an additional 106,069 shares during the period. International Assets Investment Management LLC’s holdings in Teladoc Health were worth $2,414,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Acadian Asset Management LLC bought a new position in shares of Teladoc Health in the first quarter worth approximately $27,000. Dark Forest Capital Management LP raised its holdings in shares of Teladoc Health by 408.2% during the first quarter. Dark Forest Capital Management LP now owns 1,245 shares of the health services provider’s stock valued at $32,000 after purchasing an additional 1,000 shares during the last quarter. Tyler Stone Wealth Management purchased a new position in shares of Teladoc Health during the second quarter valued at approximately $33,000. Quarry LP purchased a new position in shares of Teladoc Health during the first quarter valued at approximately $35,000. Finally, IFP Advisors Inc raised its holdings in shares of Teladoc Health by 201.5% during the second quarter. IFP Advisors Inc now owns 1,969 shares of the health services provider’s stock valued at $50,000 after purchasing an additional 1,316 shares during the last quarter. Institutional investors own 76.82% of the company’s stock.

Insider Buying and Selling

In related news, EVP Andrew Turitz sold 6,190 shares of the company’s stock in a transaction on Monday, March 4th. The shares were sold at an average price of $14.52, for a total transaction of $89,878.80. Following the completion of the transaction, the executive vice president now owns 39,429 shares in the company, valued at $572,509.08. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. In related news, EVP Andrew Turitz sold 6,190 shares of the company’s stock in a transaction on Monday, March 4th. The shares were sold at an average price of $14.52, for a total transaction of $89,878.80. Following the completion of the transaction, the executive vice president now owns 39,429 shares in the company, valued at $572,509.08. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Jason N. Gorevic sold 53,755 shares of the company’s stock in a transaction on Monday, March 4th. The stock was sold at an average price of $14.52, for a total transaction of $780,522.60. Following the transaction, the chief executive officer now owns 653,073 shares of the company’s stock, valued at approximately $9,482,619.96. The disclosure for this sale can be found here. Over the last quarter, insiders sold 135,441 shares of company stock worth $2,038,251. 1.63% of the stock is owned by insiders.

Teladoc Health Stock Performance

TDOC opened at $12.99 on Friday. The firm has a market cap of $2.20 billion, a P/E ratio of -9.69 and a beta of 0.94. Teladoc Health, Inc. has a 1-year low of $12.85 and a 1-year high of $30.41. The company has a 50 day simple moving average of $15.59 and a two-hundred day simple moving average of $17.91. The company has a debt-to-equity ratio of 0.66, a current ratio of 3.54 and a quick ratio of 3.47.

Teladoc Health (NYSE:TDOC) last posted its quarterly earnings results on Tuesday, February 20th. The health services provider reported ($0.17) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.22) by $0.05. The business had revenue of $660.50 million during the quarter, compared to analyst estimates of $670.79 million. Teladoc Health had a negative net margin of 8.47% and a negative return on equity of 9.22%. The company’s revenue was up 3.6% on a year-over-year basis. During the same period in the prior year, the business posted ($0.23) earnings per share. Equities analysts forecast that Teladoc Health, Inc. will post -1.07 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several research firms have recently weighed in on TDOC. Royal Bank of Canada decreased their price objective on shares of Teladoc Health from $30.00 to $25.00 and set an “outperform” rating for the company in a report on Wednesday, February 21st. Needham & Company LLC reissued a “hold” rating on shares of Teladoc Health in a report on Friday, April 5th. Cantor Fitzgerald assumed coverage on shares of Teladoc Health in a report on Thursday, February 29th. They set an “overweight” rating and a $22.00 price objective for the company. Piper Sandler reduced their target price on shares of Teladoc Health from $30.00 to $25.00 and set an “overweight” rating for the company in a report on Wednesday, February 21st. Finally, Truist Financial reduced their target price on shares of Teladoc Health from $23.00 to $17.00 and set a “hold” rating for the company in a report on Wednesday, March 6th. Eight research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $22.23.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.